Risk Factors for Cognitive Impairment in Patients with Type 2 Diabetes

Objectives. To investigate the risk factors for cognitive impairment in Chinese type 2 diabetes mellitus (T2DM) patients of advanced age and to identify effective biomarkers of mild cognitive impairment (MCI) in these patients. Methods. Chinese T2DM patients (n=120) aged 50–70 years were divided int...

Full description

Saved in:
Bibliographic Details
Main Authors: Lin Sun, Xue Diao, Xiaokun Gang, You Lv, Xue Zhao, Shuo Yang, Ying Gao, Guixia Wang
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2020/4591938
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561582499954688
author Lin Sun
Xue Diao
Xiaokun Gang
You Lv
Xue Zhao
Shuo Yang
Ying Gao
Guixia Wang
author_facet Lin Sun
Xue Diao
Xiaokun Gang
You Lv
Xue Zhao
Shuo Yang
Ying Gao
Guixia Wang
author_sort Lin Sun
collection DOAJ
description Objectives. To investigate the risk factors for cognitive impairment in Chinese type 2 diabetes mellitus (T2DM) patients of advanced age and to identify effective biomarkers of mild cognitive impairment (MCI) in these patients. Methods. Chinese T2DM patients (n=120) aged 50–70 years were divided into groups with impaired (mild, moderate, and severe) and normal cognitive function based on Montreal Cognitive Assessment and Mini-Mental State Examination scores. Data regarding demographic characteristics, clinical features of diabetes, biochemical markers, and metabolomics were collected. Results. Age, educational level, duration of diabetes, fasting blood glucose (FBG), HbA1c, total cholesterol (TC), triglyceride (TG), and 24-hour urine protein were significantly associated with cognitive impairment in T2DM patients of advanced age. The severity of fundus retinopathy and the incidence of macrovascular disease also differed significantly among the groups (P<0.05). Metabolomics analysis suggested that increased levels of glutamate (Glu), phenylalanine (Phe), tyrosine (Tyr), proline (Pro), and homocysteine (Hcy) and a decreased level of glutamine (Gln) were significantly associated with cognitive impairment in the T2DM patients (P<0.05). Receiver operating characteristic curve analysis demonstrated that Glu, Gln, Phe, and Pro levels were significant predictors of cognitive impairment in the T2DM patients. Conclusions. Age, educational level, duration of diabetes, and the levels of FBG, HbA1c, TC, TG, and 24-hour urine protein were considered as independent risk factors for cognitive impairment in older T2DM patients. Macrovascular and microvascular diseases also were closely associated with cognitive impairment in these patients. Together, Glu and Gln levels may represent a good predictive biomarker for the early diagnosis of cognitive impairment in T2DM patients.
format Article
id doaj-art-a199d06b21184e61906165636ccd330b
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-a199d06b21184e61906165636ccd330b2025-02-03T01:24:39ZengWileyJournal of Diabetes Research2314-67452314-67532020-01-01202010.1155/2020/45919384591938Risk Factors for Cognitive Impairment in Patients with Type 2 DiabetesLin Sun0Xue Diao1Xiaokun Gang2You Lv3Xue Zhao4Shuo Yang5Ying Gao6Guixia Wang7Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, 130021 Jilin Province, ChinaDepartment of Endocrinology and Metabolism, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518000, Guangdong Province, ChinaDepartment of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, 130021 Jilin Province, ChinaDepartment of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, 130021 Jilin Province, ChinaDepartment of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, 130021 Jilin Province, ChinaDepartment of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, 130021 Jilin Province, ChinaDepartment of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, 130021 Jilin Province, ChinaDepartment of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, 130021 Jilin Province, ChinaObjectives. To investigate the risk factors for cognitive impairment in Chinese type 2 diabetes mellitus (T2DM) patients of advanced age and to identify effective biomarkers of mild cognitive impairment (MCI) in these patients. Methods. Chinese T2DM patients (n=120) aged 50–70 years were divided into groups with impaired (mild, moderate, and severe) and normal cognitive function based on Montreal Cognitive Assessment and Mini-Mental State Examination scores. Data regarding demographic characteristics, clinical features of diabetes, biochemical markers, and metabolomics were collected. Results. Age, educational level, duration of diabetes, fasting blood glucose (FBG), HbA1c, total cholesterol (TC), triglyceride (TG), and 24-hour urine protein were significantly associated with cognitive impairment in T2DM patients of advanced age. The severity of fundus retinopathy and the incidence of macrovascular disease also differed significantly among the groups (P<0.05). Metabolomics analysis suggested that increased levels of glutamate (Glu), phenylalanine (Phe), tyrosine (Tyr), proline (Pro), and homocysteine (Hcy) and a decreased level of glutamine (Gln) were significantly associated with cognitive impairment in the T2DM patients (P<0.05). Receiver operating characteristic curve analysis demonstrated that Glu, Gln, Phe, and Pro levels were significant predictors of cognitive impairment in the T2DM patients. Conclusions. Age, educational level, duration of diabetes, and the levels of FBG, HbA1c, TC, TG, and 24-hour urine protein were considered as independent risk factors for cognitive impairment in older T2DM patients. Macrovascular and microvascular diseases also were closely associated with cognitive impairment in these patients. Together, Glu and Gln levels may represent a good predictive biomarker for the early diagnosis of cognitive impairment in T2DM patients.http://dx.doi.org/10.1155/2020/4591938
spellingShingle Lin Sun
Xue Diao
Xiaokun Gang
You Lv
Xue Zhao
Shuo Yang
Ying Gao
Guixia Wang
Risk Factors for Cognitive Impairment in Patients with Type 2 Diabetes
Journal of Diabetes Research
title Risk Factors for Cognitive Impairment in Patients with Type 2 Diabetes
title_full Risk Factors for Cognitive Impairment in Patients with Type 2 Diabetes
title_fullStr Risk Factors for Cognitive Impairment in Patients with Type 2 Diabetes
title_full_unstemmed Risk Factors for Cognitive Impairment in Patients with Type 2 Diabetes
title_short Risk Factors for Cognitive Impairment in Patients with Type 2 Diabetes
title_sort risk factors for cognitive impairment in patients with type 2 diabetes
url http://dx.doi.org/10.1155/2020/4591938
work_keys_str_mv AT linsun riskfactorsforcognitiveimpairmentinpatientswithtype2diabetes
AT xuediao riskfactorsforcognitiveimpairmentinpatientswithtype2diabetes
AT xiaokungang riskfactorsforcognitiveimpairmentinpatientswithtype2diabetes
AT youlv riskfactorsforcognitiveimpairmentinpatientswithtype2diabetes
AT xuezhao riskfactorsforcognitiveimpairmentinpatientswithtype2diabetes
AT shuoyang riskfactorsforcognitiveimpairmentinpatientswithtype2diabetes
AT yinggao riskfactorsforcognitiveimpairmentinpatientswithtype2diabetes
AT guixiawang riskfactorsforcognitiveimpairmentinpatientswithtype2diabetes